Mico BioMed Reports Operating Loss of 19.3 Billion KRW Last Year... Continued Deficit
Mico Biomed announced that its operating loss last year was 19.3 billion KRW, continuing its deficit. The net loss for the period was 25.7 billion KRW.
Hot Picks Today
"10 Million Won Grows to 2.18 Billion"... 'Father of ETFs' Recommends This Stock for Grandchildren [KOSPI 10,000 Era]
- "Don't Quit, We'll Give You a 50 Million Won Bonus"...This Company Takes Drastic Measures to Retain Talent
- Fired Over a $2 Snack: Why a 300 Million KRW Engineer Lost His Job
- Coupang CFS to Fully Compensate Merchants for Losses at Incheon Logistics Center
- "Joey Wong Returns After 22 Years: The Secret Behind Her Unchanging Beauty"
The company explained that sales in the molecular diagnostics sector (PCR devices and reagents, etc.) and the immunodiagnostics sector (RDT kits, etc.) decreased due to the transition to the COVID-19 endemic phase.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.